This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing UniQure's AMT-130 in Huntington's disease ahead of the 3 year update
Ticker(s): QUREWho's the expert?
Institution: Georgetown University
- Neuropsychiatrist and Director of the Huntington’s Disease Care, Education and Research Center at MedStar Georgetown University Hospital
- Manages over 250 patients with Huntington's Disease
- Currently the co-principal investigator on several clinical trial studying Huntington’s disease, tardive dyskinesia, Parkinson’s disease, brain injury and Alzheimer’s disease.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
